ArticleFrontiers in oncology2026
Intraoperative electrocorticography-guided glioma surgery: impact on extent of resection and functional preservation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Direct cortical stimulation (DCS) remains the gold standard for functional mapping in glioma surgery; however, its reliability may be limited by glioma-induced neural remodeling, incomplete motor mapping, and intraoperative constraints. We investigated whether supplementing DCS with electrocorticography (ECoG) for intraoperative functional mapping and tumor boundary delineation improves extent of resection (EOR) and neurological outcomes in glioma surgeries. Methods: We conducted a single-center retrospective cohort study of 120 adults with supratentorial gliomas who underwent surgery between June 2021 and April 2024. Patients underwent awake or general anesthesia craniotomy with intraoperative mapping using DCS alone or DCS combined with ECoG. They were stratified into four groups: AC-ECoG (awake with DCS only, n=34), AC+ECoG (awake with DCS+ECoG, n=30), GA-ECoG (general anesthesia with DCS only, n=28), and GA+ECoG (general anesthesia with DCS+ECoG, n=28). Intraoperative ECoG was used for both functional mapping and tumor delineation. Multivariable linear regression evaluated ECoG's independent effect on EOR and 6-month outcomes (KPS, MoCA, MMSE), adjusting for tumor characteristics and patient factors. Descriptive subgroup analyses compared outcomes across anesthesia and mapping modalities. Results: ECoG independently predicted higher EOR (β=3.3, p<0.001) and 6-month KPS (β=5.1, p=0.025), MoCA (β=1.8, p=0.003), and MMSE (β=3.0, p=0.024). Higher Ki-67 (≥10%) predicted lower EOR (β=-2.0, p=0.024). Subgroup analyses further demonstrated this effect, with ECoG-guided surgeries achieving higher EOR, smaller residual volumes, and improved early cognitive outcomes. Conclusion: Intraoperative ECoG independently improves extent of resection and early functional outcomes across anesthesia paradigms, supporting its role as a valuable adjunct to DCS in glioma surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.